These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 935655)

  • 1. The distribution of halofenate in plasma: a comparative analysis using Scatchard vs. stepwise association constants.
    Wosilait WD; Nagy P
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):75-81. PubMed ID: 935655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical analysis of the distribution of quinidine in the plasma: the relationship between protein binding and therapeutic drug levels.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):147-54. PubMed ID: 1188181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of furosemide to albumin isolated from human fetal and adult serum.
    Viani A; Cappiello M; Silvestri D; Pacifici GM
    Dev Pharmacol Ther; 1991; 16(1):33-40. PubMed ID: 1879250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
    Cham BE; Bochner F; Imhoff DM; Byrne G; Gunsberg M
    J Pharmacol Exp Ther; 1982 Mar; 220(3):648-53. PubMed ID: 7062274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between halofenate and propranolol.
    Huffman DH; Azarnoff DL; Shoeman DW; Dujovne CA
    Clin Pharmacol Ther; 1976 Jun; 19(6):807-12. PubMed ID: 773588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mefenaminic acid binding by blood plasma and organ homogenates].
    Vinnikova AV; Trinus FP; Denisov ND; Luĭk AI
    Farmakol Toksikol; 1980; 43(2):187-92. PubMed ID: 7439360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of halofenate on the serum binding of phenytoin.
    Karch FE; Wardell WM; Dambly M; Gringeri A
    Br J Clin Pharmacol; 1977 Oct; 4(5):625-6. PubMed ID: 911611
    [No Abstract]   [Full Text] [Related]  

  • 10. A new aspect of serum protein binding of tolbutamide.
    Ayanoğlu G; Uihlein M; Grigoleit HG
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):65-8. PubMed ID: 3957494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation.
    Minsker DH; Jordan PT; Kling P; MacMillan A; Hucker HB
    Thromb Haemost; 1976 Apr; 35(2):358-63. PubMed ID: 989636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer analysis of drug-protein binding data.
    Fletcher JE; Ashbrook JD; Spector AA
    Ann N Y Acad Sci; 1973 Nov; 226():69-81. PubMed ID: 4520404
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
    McDonnell PA; Caldwell GW; Masucci JA
    Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding characteristics of bumetanide.
    Walker PC; Berry NS; Edwards DJ
    Dev Pharmacol Ther; 1989; 12(1):13-8. PubMed ID: 2721330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of methotrexate to human albumin and serum. A first derivative spectroscopic analysis.
    Rochas MA; Tufenkji AE; Levillain P; Houin G
    Arzneimittelforschung; 1991 Dec; 41(12):1286-8. PubMed ID: 1815530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.